|
HS Code |
318311 |
| Product Name | 3-Bromo-5-Chloro-2-Fluoropyridine |
| Cas Number | 884494-73-1 |
| Molecular Formula | C5H2BrClFN |
| Molecular Weight | 210.44 g/mol |
| Appearance | Colorless to light yellow liquid |
| Boiling Point | 188-190 °C |
| Purity | Typically ≥ 97% |
| Density | 1.78 g/cm³ (approximate) |
| Solubility | Soluble in organic solvents (e.g., dichloromethane, ether) |
| Smiles | C1=CN=C(C(=C1Cl)Br)F |
| Inchi | InChI=1S/C5H2BrClFN/c6-4-1-9-5(8)2-3(4)7 |
| Hazard Class | Irritant |
| Refractive Index | 1.564 (approximate) |
| Storage Conditions | Store in a cool, dry, well-ventilated area |
As an accredited 3-Bromo-5-Chloro-2-Fluoropyridine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 3-Bromo-5-Chloro-2-Fluoropyridine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Stepping into a research lab today, the shelves and storage cabinets reveal quite a range of fine chemicals, but certain names stand out for the frequency of use and reliability. 3-Bromo-5-Chloro-2-Fluoropyridine holds a steady position in that lineup. Bearing the chemical formula C5H2BrClFN, this heterocyclic compound often arrives as a light yellow solid or sometimes as a crystalline powder, depending on the grade and storage conditions. Its molecular weight swings in just above 210 g/mol, and the structure—marked by bromine at position 3, chlorine at 5, and fluorine at 2 on the pyridine ring—invites targeted reactivity often sought in pharmaceutical projects and agrochemical development.
Beyond the catalog entry and chemical shorthand, the value of 3-Bromo-5-Chloro-2-Fluoropyridine surfaces during actual experimental work. Say you’re working up a library of small-molecule candidates for kinase inhibition. This compound gives medicinal chemists room to maneuver with its distinct blend of halogen substituents, which change how the molecule interacts with enzymes and biological targets. Compared to many simple halopyridines, the arrangement on this ring isn’t arbitrary—it’s built for selectivity, for tuning solubility, for getting the kind of bioavailability that brings real results to screening workflows.
The interplay between fluorine’s electron-withdrawing nature and the presence of the larger bromine and chlorine atoms enables strategic coupling reactions. In Suzuki or Buchwald-Hartwig couplings, for example, the bromine site demonstrates reactivity suitable for cross-coupling without excessive byproduct formation, conserving both time and material. This is especially significant when running multistep syntheses where compound stability and predictable reactivity can be the difference between a successful batch and a long week of troubleshooting. Having worked in a lab environment myself, I’ve seen teams lean heavily on this trifunctional pyridine while optimizing lead structures, particularly because alternatives often force a trade-off—more steps, lower yields, or complicated purification procedures.
The significance of this chemical isn’t limited to synthetic convenience or its obvious role as a building block. In medicinal chemistry, halogen placement changes the way a compound interacts with protein pockets. Modifying the ring with bromine and chlorine at these specific positions lets research groups probe the effect of steric bulk and electronic character right where it counts—affecting binding affinity or metabolic stability. Fluorine, highly electronegative but small in size, often helps increase the binding strength or block sites prone to metabolic degradation. In practice, this means a candidate molecule that sticks longer in vivo or presents a different profile in liver microsome stability assays.
I recall a project where variations of halopyridines were lined up for screening, only to notice that simply moving a fluorine atom made a considerable difference in the metabolic half-life. The syntheses involving 3-Bromo-5-Chloro-2-Fluoropyridine provided a way to probe these changes efficiently, and gave us the chance to learn how subtle ring modifications produced new SAR (structure-activity relationship) insights. Often, standard analogs like 2-bromo-5-fluoro or 3-chloro-2-fluoro variants didn’t produce the same dramatic improvements, especially in late-stage optimization.
Research teams in pharma, agrochemical, and specialty chemical sectors have put this compound to work in many routes. In the pharma sector, its main draw comes from its ability to serve as a platform for further elaboration into drugs acting on central nervous system targets or kinases. The pyridine core remains a favorite scaffold in drug design, and having multiple, orthogonally reactive halogen sites means chemists get to apply site-selective transformations—swapping halogens, adding substituents, or installing moieties needed for better pharmacokinetics.
A handful of agrochemical discoveries started out with pyridine templates similar to this one. When exploring insecticide or herbicide candidates, chemists find the placement of halogen atoms often shifts soil and water solubility, environmental persistence, or target selectivity. For instance, the combined effect of bromine and chlorine tends to raise the logP, giving rise to different partitioning behaviors in environmental tests. Fluoropyridines have a reputation for enhancing bioactivity, and introducing the third halogen can further push compounds past roadblocks encountered with standard dichloropyridines or difluoropyridines.
The synthesis of complex molecules in academic settings, too, gains efficiency by using this compound. Graduate students running cross-coupling reactions find that bromine at the meta-position reacts predictably with aryl boronic acids under standard Suzuki conditions. Chlorine’s presence at position 5 offers a less reactive site, reserved for subsequent steps where a later-stage transformation might be needed for positional selectivity. In synthetic strategy, that flexibility reduces the need to protect and deprotect groups constantly—lifting some of the burden from already tight timelines.
Surveying the marketplace, the contrast between 3-Bromo-5-Chloro-2-Fluoropyridine and simpler analogs becomes apparent. A standard 2,3-dichloropyridine or mono-halogenated variant might offer baseline reactivity but lacks the breadth of application, particularly in the hands of those in medicinal and process chemistry. The triple-substituted scaffold finds favor among synthetic chemists looking for differentiated approaches—especially as issues like intellectual property clearance demand structures off the beaten path.
One aspect of distinction flows from the halogen mix itself. Mono-fluorinated pyridines introduce electron-withdrawing capability, impacting reactivity in palladium-catalyzed couplings, but without additional halogens, options stay somewhat boxed in. Add both bromine and chlorine on the ring, and the options for orthogonal functionalization open up. Chemists can plan sequences with more freedom, prioritizing steps based on ease of isolation or yield improvements along the line.
Having handled both mono- and di-halopyridines, the increased versatility and target specificity of 3-Bromo-5-Chloro-2-Fluoropyridine shows up in both exploratory labs and process-scale kilo labs. Mono-halogenated species often find quick utility in simple transformations or as raw material for libraries, but as projects move downstream—toward process development or scale-up—the additional halogens prove valuable for modifying physical properties. Changes in boiling point, crystallization habits, or solvent compatibility shape real-world synthesis more than anything captured by theory alone.
The abundance of halogens attached to a pyridine ring like this one isn’t just a spectacle for a molecular model kit; it translates into broader reach for method development. Both medicinal and process chemists exploit these features when devising synthetic routes. Sometimes, the presence of three, differently placed halogens lets teams shift a late-stage functionalization to an earlier step, increasing overall yields or troubleshooting bottlenecks that stubbornly resist known workarounds.
During a recent consultation for a process optimization project, teams faced recurring problems with a sluggish, low-yielding amination step. Swapping in 3-Bromo-5-Chloro-2-Fluoropyridine allowed the amine to be installed through palladium catalysis with notable improvements in both purity and ease of workup. The less reactive chlorine site held fast for downstream steps, giving extra room for process flexibility. Crop protection R&D labs benefit in a similar way; the tolerance of various reagents and process conditions mean they’re less likely to hit unanticipated dead ends during scale-up.
Some researchers in academic circles are exploring big-picture questions about C–N and C–C bond formation. The pattern of halogens here turns the molecule into a platform for testing new catalytic systems and pushing for greener processes. I’ve seen reports where 3-Bromo-5-Chloro-2-Fluoropyridine provided the substrate for palladium, copper, or nickel catalysis, each with its unique fingerprints on regioselectivity and byproduct generation. These collaborations between method developers and practicing synthetic chemists move the whole field forward.
From direct experience in synthetic labs, a compound can earn or lose its place on the shelf based on more than numbers on a spec sheet. 3-Bromo-5-Chloro-2-Fluoropyridine generally offers stable storage, resisting moisture and light degradation under standard conditions. It dissolves easily in polar aprotic solvents such as dimethylformamide or acetonitrile, making it a reliable feed for both manual reactions and automated, flow-based set-ups. Problems, such as hydrolysis or decomposition, tend to crop up only with prolonged exposure to strong acids or bases—nothing out of the ordinary for a trisubstituted aromatic.
Purification, whether by column or crystallization, rarely throws unexpected challenges, reinforcing the chemical’s reputation for straightforward handling. In kilo lab or manufacturing settings, teams track purity closely—often using HPLC or GC to keep tabs on byproducts. The compound’s melting point comes in around the mid two hundreds Celsius, remaining robust through most routine reaction cycles, unlike some dihalogenated analogs, which suffer from volatility or breakdown under similar conditions.
For newcomers to synthesis, 3-Bromo-5-Chloro-2-Fluoropyridine doesn’t demand unusual precautions, outside the typical standards for minor toxicity of halogenated aromatics. Standard PPE and ventilation suffice. People working hands-on often remark on the absence of strong odors—a small mercy compared to some alternatives, which can render a shared fume hood unpleasant for days. This all adds up to smoother project milestones and cleaner workspaces, two things any veteran chemist will tell you are worth their weight in gold.
As valuable as this compound has become, there’s always pressure to push further. Sourcing at scale sometimes runs into hiccups, especially when supply chains tighten around brominated or fluorinated starting materials. Global events or regulatory changes restricting these chemicals at the upstream end can send ripples through the fine chemical supply. Pricing reflects not just raw ingredient cost, but also the complexity of halogen incorporation, which isn’t trivial. In my own purchasing experience, bulk lots of 3-Bromo-5-Chloro-2-Fluoropyridine often require early forecasting and direct negotiation with suppliers familiar with custom synthesis and long lead times.
Safety and environmental impact also rise up as topics for continued attention. Multihalogenated aromatics don’t always enjoy straightforward waste pathways, and process chemists increasingly look to minimize off-gassing, solvent use, and halogenated byproducts. Upstream, research pushes for greener synthetic routes—sometimes through one-pot processes or by swapping out hazardous reagents for those less likely to create downstream emissions. Efforts here can spill benefits into other chemistries, raising standards across the field.
When it comes to patent clearance, the uniqueness of 3-Bromo-5-Chloro-2-Fluoropyridine’s structure sometimes comes under scrutiny—as research into halopyridines expands, the need for distinct intellectual property claims ramps up. Companies constantly search for new substitution patterns to dodge overlap with existing filings. That search, in turn, keeps demand high for building blocks with fresh patterns, which this compound exemplifies. I’ve watched colleagues work tirelessly to generate new analogs around this core, testing every possible variation in a bid to secure both utility and innovation.
No single compound solves every problem in synthesis, and new generations of building blocks constantly compete for a place on the chemist’s bench. Some teams have experimented with other multi-substituted pyridine scaffolds—incorporating nitrogen heterocycles or moving halogen atoms to different locations on the ring. Each tweak delivers its own set of reactivity and pharmacological properties, but few offer the same balance of cross-coupling readiness, site selectivity, and biological value seen with 3-Bromo-5-Chloro-2-Fluoropyridine.
Machine learning in synthetic planning brings additional layers of optimization to route scouting. Algorithms sort through libraries and forecast which halogenated pyridines will deliver the best blend of reaction success and downstream performance. Early tests in digital retrosynthesis suggest this molecule turns up repeatedly as a favored node in multi-step networks, reflecting its robust, predictable chemistry and broad engagement with commonly used transformations.
On the industrial front, modular synthesis modules and flow chemistry have shown particular affinity for substrates like 3-Bromo-5-Chloro-2-Fluoropyridine, which play nicely with high-throughput automation. By anchoring new methods and giving better control over heat, pressure, and solvent profile, process chemists keep pushing what these building blocks can enable. These advances mean that, far from being static, this compound keeps pace with the latest manufacturing technologies, extending its shelf life both literally and metaphorically in the ever-changing research sphere.
To keep pace with demand for safe, sustainable, and high-performance building blocks, several strategies have gained momentum. Greater recycling and recovery of halogenated solvents, coupled with advances in catalytic systems that tolerate more benign conditions, can shrink the environmental footprint. In projects I’ve observed, waste minimization efforts have reduced both byproduct generation and the cost of downstream purification. Companies now spend more to recover and reuse, but save double once regulatory disposal costs and procurement delays fall.
Where raw material shortages threaten to stall synthesis, collaborative partnerships between suppliers and researchers help keep the pipeline flowing. Advanced forecasting, supported by digital inventory management, keeps bottlenecks from becoming crises. In cases where traditional manufacturing routes hit roadblocks, some labs test alternative halogen sources or use continuous-flow microreactors to stretch raw supplies and create less batch-to-batch variability. Peer-reviewed studies increasingly share greener workflows and prioritize raw material flexibility, giving industry players the tools and know-how to adapt when shortages arise.
Intellectual property challenges call for creative medicinal chemistry alongside legal expertise. Teams looking to distinguish their projects often leverage the unique reactivity of 3-Bromo-5-Chloro-2-Fluoropyridine, designing custom-tailored analogs that meet both functional demands and clear freedom to operate. Open innovation partnerships speed up preclinical discovery and encourage early exchange of ideas, reducing overlap and duplication across the research landscape.
As the pharmaceutical world braces for ever tighter regulatory and cost environments, compounds like 3-Bromo-5-Chloro-2-Fluoropyridine will likely keep their appeal. The only way to stay ahead—at least from experience—is to keep refining synthetic approaches, feedstock sourcing, and end-product purification. Young chemists, increasingly trained with computational tools and green chemistry principles, are finding new ways to extract more versatility and fewer waste streams from each molecule. In projects I’ve observed, students and postdocs learn to see beyond yield and purity, aiming for routes that save energy, time, and environmental resources.
Consumer safety and demand for transparent supply chains shape more of the specialty chemical landscape each year. Traceability—from precursor to packaged product—has become essential. Researchers and suppliers document each synthetic step, packaging lot, and delivery endpoint. New digital platforms track quality, ensuring what arrives in the vial or drum matches what’s expected, both chemically and performance-wise. This level of detail, shaped by the demands of health and environmental safety, brings more accountability and ultimately higher standards to everyone involved.
Throughout my years in the lab, the products that stuck were those easy to handle, flexible in use, and able to punch above their weight when the pressure was on. 3-Bromo-5-Chloro-2-Fluoropyridine fits that bill, not only for its chemistry but for its role in supporting the new ambitions of synthetic research—a field now measured as much by creativity, safety, and sustainability as by raw productivity.